Serum immune markers and transition to psychosis in individuals at clinical high risk

[1]  J. Raduà,et al.  Probability of Transition to Psychosis in Individuals at Clinical High Risk: An Updated Meta-analysis. , 2021, JAMA psychiatry.

[2]  G. Cagney,et al.  Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis , 2021, Molecular Psychiatry.

[3]  K. Heekeren,et al.  Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression , 2020, JAMA psychiatry.

[4]  B. Miller,et al.  Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis , 2020, Schizophrenia Research.

[5]  G. Pearlson,et al.  Multivariate Relationships Between Peripheral Inflammatory Marker Subtypes and Cognitive and Brain Structural Measures in Psychosis , 2020, Molecular Psychiatry.

[6]  M. Cho,et al.  A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19 , 2020, EBioMedicine.

[7]  G. Cagney,et al.  Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence , 2020, JAMA psychiatry.

[8]  P. Delespaul,et al.  Dysregulated Lipid Metabolism Precedes Onset of Psychosis , 2020, Biological Psychiatry.

[9]  B. Penninx,et al.  Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis , 2020, Brain, Behavior, and Immunity.

[10]  P. McGuire,et al.  Emotion Recognition and Adverse Childhood Experiences in Individuals at Clinical High Risk of Psychosis. , 2020, Schizophrenia bulletin.

[11]  M. D. Forti,et al.  Baseline high levels of complement component 4 predict worse clinical outcome at 1-year follow-up in first-episode psychosis , 2020, Brain, Behavior, and Immunity.

[12]  P. McGuire,et al.  Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis , 2019, JAMA psychiatry.

[13]  Tyrone D. Cannon,et al.  Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk. , 2019, The American journal of psychiatry.

[14]  R. Upthegrove,et al.  Cytokines, Oxidative Stress and Cellular Markers of Inflammation in Schizophrenia. , 2019, Current topics in behavioral neurosciences.

[15]  R. Murray,et al.  Associations Between Non-neurological Autoimmune Disorders and Psychosis: A Meta-analysis , 2019, Biological Psychiatry.

[16]  M. D. Forti,et al.  Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis , 2019, Psychoneuroendocrinology.

[17]  O. Howes,et al.  A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis , 2018, Schizophrenia bulletin.

[18]  F. Smit,et al.  Child Maltreatment and Clinical Outcome in Individuals at Ultra-High Risk for Psychosis in the EU-GEI High Risk Study , 2018, Schizophrenia bulletin.

[19]  L. Kodjikian,et al.  USE OF A THRESHOLD OF INTERLEUKIN-10 AND IL-10/IL-6 RATIO IN OCULAR SAMPLES FOR THE SCREENING OF VITREORETINAL LYMPHOMA , 2017, Retina.

[20]  F. Turkheimer,et al.  Brain microglia in psychiatric disorders. , 2017, The lancet. Psychiatry.

[21]  S. Sherman,et al.  Insights into the Mechanisms Involved in Protective Effects of VEGF-B in Dopaminergic Neurons , 2017, Parkinson's disease.

[22]  Wei Wu,et al.  Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma , 2016, Scientific Reports.

[23]  D. Goldsmith,et al.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression , 2016, Molecular Psychiatry.

[24]  S. Smesny,et al.  Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder? , 2016, BMC Psychiatry.

[25]  M. Keshavan,et al.  Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study , 2016, Schizophrenia Research.

[26]  B. Ham,et al.  Alterations in plasma vascular endothelial growth factor levels in patients with schizophrenia before and after treatment , 2015, Psychiatry Research.

[27]  R. Yolken,et al.  Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset , 2015, Translational Psychiatry.

[28]  R. Murray,et al.  Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis , 2015, Schizophrenia bulletin.

[29]  Tyrone D. Cannon,et al.  Progressive Reduction in Cortical Thickness as Psychosis Develops: A Multisite Longitudinal Neuroimaging Study of Youth at Elevated Clinical Risk , 2015, Biological Psychiatry.

[30]  Tyrone D. Cannon,et al.  Towards a Psychosis Risk Blood Diagnostic for Persons Experiencing High-Risk Symptoms: Preliminary Results From the NAPLS Project , 2014, Schizophrenia bulletin.

[31]  R. Murray,et al.  Serum and gene expression profile of cytokines in first-episode psychosis , 2013, Brain, Behavior, and Immunity.

[32]  Jeremy Seto,et al.  Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. , 2012, The Journal of clinical investigation.

[33]  R. Murray,et al.  Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. , 2011, The American journal of psychiatry.

[34]  R. Murray,et al.  Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume. , 2011, The Journal of clinical psychiatry.

[35]  T. Murata,et al.  [Vascular endothelial growth factor (VEGF)]. , 2010, Nihon rinsho. Japanese journal of clinical medicine.

[36]  Gemma C. Garriga,et al.  Permutation Tests for Studying Classifier Performance , 2009, 2009 Ninth IEEE International Conference on Data Mining.

[37]  Larry J. Seidman,et al.  NEUROPSYCHOLOGY OF THE PRODROME TO PSYCHOSIS IN THE NAPLS CONSORTIUM: RELATIONSHIP TO FAMILY HISTORY AND CONVERSION TO PSYCHOSIS , 2008, Schizophrenia Research.

[38]  J. Feldon,et al.  Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling , 2008, Molecular Psychiatry.

[39]  K. Plate,et al.  Different networks, common growth factors: shared growth factors and receptors of the vascular and the nervous system , 2007, Acta Neuropathologica.

[40]  M. Yücel,et al.  Neuroimaging and emerging psychotic disorders: The Melbourne ultra-high risk studies , 2007, International review of psychiatry.

[41]  A. Yung,et al.  Mapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States , 2005 .

[42]  C. Pantelis,et al.  Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. , 2005, Schizophrenia bulletin.

[43]  M. Popoli,et al.  Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia , 2002, Biological Psychiatry.

[44]  E. Oldfield,et al.  Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. , 1999, Journal of neuropathology and experimental neurology.

[45]  W. Silverman,et al.  Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures , 1999, Neuroscience.

[46]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[47]  D. Quade.  Using Weighted Rankings in the Analysis of Complete Blocks with Additive Block Effects , 1979 .

[48]  P. McGuire,et al.  The blood-brain barrier in psychosis. , 2018, The lancet. Psychiatry.

[49]  E. Vilella,et al.  Stress biomarkers as predictors of transition to psychosis in at-risk mental states: roles for cortisol, prolactin and albumin. , 2015, Journal of psychiatric research.